#USA #Nashville #OneOncology #Emily Touloukian #Coastal Cancer Center

OneOncology Appoints Emily Touloukian, DO, to Board of Managers

In a significant move to enhance its leadership, OneOncology has appointed Dr. Emily Touloukian, a distinguished medical professional and leader in the oncology field, to its Board of Managers. The announcement was made on September 17, 2025, and marks a strategic step for OneOncology, an organization dedicated to empowering independent medical specialty practices across the nation.

Dr. Touloukian is the President and CEO of Coastal Cancer Center located in Myrtle Beach, South Carolina. Bringing a wealth of experience and expertise, she is board-certified in medical oncology, hematology, and internal medicine. Her extensive background also includes sitting on the Board of Directors for the Community Oncology Alliance and serving as past president of the South Carolina Oncology Society. Currently, she holds the position of president of the Medical Society of Horry County, showcasing her commitment to improving the local healthcare landscape.

Emily Touloukian joins a notable group of physician leaders on OneOncology’s Board, including Dr. Eric Mininberg, who was appointed in 2024. With her addition, the Board now comprises nine physicians out of fourteen members, emphasizing OneOncology's commitment to physician leadership. This robust representation of practicing physicians is instrumental in guiding and promoting the organization’s mission to empower medical practices and enhance patient care in local communities.

Dr. Jeff Patton, CEO of OneOncology, expressed his enthusiasm about Dr. Touloukian’s appointment, stating, “I’m thrilled to welcome Dr. Touloukian to the Board. We look forward to working with her to continue growing OneOncology and to further empower our physician partners with a world-class platform and experience.” His remarks reflect the organization's commitment to fostering a physician-led environment and leveraging their insights to enhance operational effectiveness and clinical innovation across the board.

To understand OneOncology’s mission, it is rooted in the belief that community physicians are best equipped to provide care tailored to local needs. Founded by a coalition of community physicians, OneOncology aims to improve the lives of individuals battling cancer and other diseases while ensuring that these specialties retain their independence. By supporting community medical practices through initiatives such as group purchasing, operational optimization, and clinical innovation, OneOncology strives to enhance patient access to healthcare at a lower cost compared to hospital settings.

Currently, OneOncology partners with 29 medical practices, which include a network of about 1,800 providers. Together, they serve nearly one million patients across 565 locations nationwide. This expansive network allows for substantial collaborative efforts in clinical excellence, patient experience, and continued advancements in cancer care.

Dr. Touloukian’s expertise in oncology and her commitment to community medical practices are expected to play a crucial role as OneOncology continues to evolve. Her leadership will not only help in addressing the challenges faced by community practices but also in spearheading initiatives that prioritize patient outcomes and local healthcare access.

For more information about OneOncology and its mission, visit their official website at oneoncology.com or follow their updates on LinkedIn.

In conclusion, the appointment of Dr. Emily Touloukian to the Board of Managers marks a pivotal moment for OneOncology. By integrating her insights and leadership experience, the organization is poised to strengthen its community-oriented approach and further advance the quality of cancer care available to patients.